1型糖尿病多种管理技术的目标范围内时间:系统评价与网状Meta分析
该系统评价与网状Meta分析检索截至2019年4月24日的多个数据库,纳入14项随机对照试验共1043例成人1型糖尿病患者,比较8种管理技术对血糖范围内时间的影响。闭环系统较每日多次注射联合毛细血管血糖监测的常规治疗,目标范围内时间平均延长17.85%(95%预测区间7.56-28.14),在目标范围内时间及高于范围时间的SUCRA排名均最佳。
要点
- 闭环系统在目标范围内时间的SUCRA排名最佳(98.5%)。
- 闭环系统较常规治疗的目标范围内时间平均延长17.85%(95%预测区间7.56-28.14)。
- 所有结局总体偏倚风险为中等,证据确定性极低。
核心结论
- 在首次综合考虑目标范围内时间的多种管理策略整合比较中,闭环系统的疗效似乎优于所有其他方法。
研究设计与样本
- 系统评价与网状Meta分析,检索Evidenced-Based Medicine Reviews、CINAHL、Embase、MEDLINE、MEDLINE In-Process & Other Non-Indexed Citations、PROSPERO、PsycInfo、PubMed和Web of Science至2019年4月24日。
- 纳入14项比较8种技术的随机对照试验,共1043例成人(≥18岁)1型糖尿病患者,排除孕妇,试验持续时间≥2周。
主要发现
- 闭环系统较每日多次注射联合毛细血管血糖监测的常规治疗,目标范围内时间平均延长17.85%(95%预测区间7.56-28.14)。
- 闭环系统在目标范围内时间和高于范围时间的SUCRA排名最佳(分别为98.5%和93.5%)。
- 闭环系统在低于范围时间的SUCRA排名也较高(62.2%)。
关键数值与推荐
- 结局指标为传感器葡萄糖水平3.9-10.0 mmol/L(70-180 mg/dL)、>10.0 mmol/L(180 mg/dL)和<3.9 mmol/L(70 mg/dL)的时间百分比。
局限性
- 所有结局的总体偏倚风险评级为中等。
- 证据确定性极低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Time in range is a key glycemic metric, and comparisons of management technologies for this outcome are critical to guide device selection. PURPOSE: We conducted a systematic review and network meta-analysis to compare and rank technologies for time in glycemic ranges. DATA SOURCES: We searched Evidenced-Based Medicine Reviews, CINAHL, Embase, MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, PROSPERO, PsycInfo, PubMed, and Web of Science until 24 April 2019. STUDY SELECTION: We included randomized controlled trials ≥2 weeks' duration comparing technologies for management of type 1 diabetes in adults (≥18 years of age), excluding pregnant women. DATA EXTRACTION: Data were extracted using a predefined template. Outcomes were percent time with sensor glucose levels 3.9-10.0 mmol/L (70-180 mg/dL), >10.0 mmol/L (180 mg/dL), and <3.9 mmol/L (70 mg/dL). DATA SYNTHESIS: We identified 16,772 publications, of which 14 eligible studies compared eight technologies comprising 1,043 participants. Closed-loop systems led to greater percent time in range than any other management strategy, and mean percent time in range was 17.85 (95% predictive interval 7.56-28.14) longer than with usual care of multiple daily injections with capillary glucose testing. Closed-loop systems ranked best for percent time in range or above range with use of Surface Under the Cumulative RAnking curve (SUCRA) (98.5% and 93.5%, respectively). Closed-loop systems also ranked highly for time below range (SUCRA 62.2%). LIMITATIONS: Overall risk of bias ratings were moderate for all outcomes. Certainty of evidence was very low. CONCLUSIONS: In the first integrated comparison of multiple management strategies considering time in range, we found that the efficacy of closed-loop systems appeared better than all other approaches.
引用
- Pease A, Lo C, Earnest A, et al. Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis. Diabetes Care. 2020. PMID: 32669412. doi:10.2337/dc19-1785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。